A randomized, investigator blind, split-face study of the efficacy of using Eucerin Dermopure to reduce mucocutaneous side effects of adapalene/benzoyl peroxide combination (Epiduo) for the treatment of acne vulgaris.
Phase 3
- Conditions
- Acne vulgarisEucerin Dermopure, irritation, mucocutaneous side effects, acne treatment, acne vulgaris
- Registration Number
- TCTR20210709005
- Lead Sponsor
- Beiersdorf Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Acne vulgaris patient
Exclusion Criteria
lactation, pregnancy, allergy to study product, use of drug-induced acne, Polycystic Ovary Syndrome (PCOS)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Irritation score week 0, week 2, week 4 interview
- Secondary Outcome Measures
Name Time Method Skin biophysics week 0, week 2, week 4 Corneometer, tewameter, pH meter ,Erythema score week 0, week 2, week 4 Visia,Patient satisfaction week 0, week 2, week 4 Patient satisfaction score